The Influence of Cell Cycle Regulation on Chemotherapy.
Reads0
Chats0
TLDR
In this paper, the authors presented the mechanism of commonly used chemotherapeutic drugs and the effect of the cell cycle on tumorigenesis and development, and the interaction between chemotherapy and cell cycle regulation in cancer treatment was briefly introduced.Abstract:
Cell cycle regulation is orchestrated by a complex network of interactions between proteins, enzymes, cytokines, and cell cycle signaling pathways, and is vital for cell proliferation, growth, and repair. The occurrence, development, and metastasis of tumors are closely related to the cell cycle. Cell cycle regulation can be synergistic with chemotherapy in two aspects: inhibition or promotion. The sensitivity of tumor cells to chemotherapeutic drugs can be improved with the cooperation of cell cycle regulation strategies. This review presented the mechanism of the commonly used chemotherapeutic drugs and the effect of the cell cycle on tumorigenesis and development, and the interaction between chemotherapy and cell cycle regulation in cancer treatment was briefly introduced. The current collaborative strategies of chemotherapy and cell cycle regulation are discussed in detail. Finally, we outline the challenges and perspectives about the improvement of combination strategies for cancer therapy.read more
Citations
More filters
Journal ArticleDOI
Robust, anti-freezing and conductive bonding of chitosan-based double-network hydrogels for stable-performance flexible electronic
Decheng Wu,Decheng Wu,Alfina Noviyanti, Yuyun Umaidah, Rini Mayasari,REJABALIYEVA TAMARA TOLIB QIZI +3 more
TL;DR: In this paper , various chitosan-polyacrylamide double-network (CS-PAM DN) ionic hydrogels were chemically linked with diverse substrates to construct robust and anti-freezing hydrogel-substrate combination.
Journal ArticleDOI
Robust, anti-freezing and conductive bonding of chitosan-based double-network hydrogels for stable-performance flexible electronic.
Yanyu Yang,Yanyu Yang,Decheng Wu,Decheng Wu,Manhua Zhou,Junbo Peng,Alfina Noviyanti, Yuyun Umaidah, Rini Mayasari,Xing Wang,REJABALIYEVA TAMARA TOLIB QIZI,Yang Liu,Wanjie Wang,Decheng Wu,Decheng Wu +12 more
TL;DR: In this paper, various chitosan-polyacrylamide double-network (CS-PAM DN) ionic hydrogels were chemically linked with diverse substrates to construct robust and anti-freezing hydrogel-substrate combination.
Journal ArticleDOI
Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer.
Gangga Anuraga,Wei-Jan Wang,Nam Nhut Phan,Nu Thuy An Ton,Hoang Dang Khoa Ta,Fidelia Berenice Prayugo,Do Thi Minh Xuan,Su-Chi Ku,Yung-Fu Wu,Vivin Andriani,Muhammad Athoillah,Kuen Haur Lee,Chih-Yang Wang +12 more
TL;DR: Zhang et al. as mentioned in this paper investigated the prognosis relationships of NEK family genes for breast cancer development, as well as the gene expression signature via the bioinformatics approach.
Journal ArticleDOI
Synthesis and characterization of curcumin-loaded pH/reduction dual-responsive folic acid modified carboxymethyl cellulose-based microcapsules for targeted drug delivery
TL;DR: In this paper, an eco-friendly, biodegradable, biocompatible, non-immunogenic and non-toxic polysaccharide, carboxymethyl cellulose (CMC), derivatived from renewable biomass cellulose, was used for designing and fabrication of a folic acid modified pH and reduction dual-responsive CARBM-based microcapsules (FA-PRCMCs).
Journal ArticleDOI
Synthesis and characterization of curcumin-loaded pH/reduction dual-responsive folic acid modified carboxymethyl cellulose-based microcapsules for targeted drug delivery
TL;DR: In this paper , an eco-friendly, biodegradable, biocompatible, nonimmunogenic, non-toxic polysaccharide, carboxymethyl cellulose (CMC), derivatived from renewable biomass cellulose, was used for designing and fabrication of a folic acid modified pH and reduction dual-responsive CARB microcapsules (FA-PRCMCs).
References
More filters
Journal ArticleDOI
CDK inhibitors: positive and negative regulators of G1-phase progression
TL;DR: This work challenges previous assumptions about how the G1/S transition of the mammalian cell cycle is governed, helps explain some enigmatic features of cell cycle control that also involve the functions of the retinoblastoma protein (Rb) and the INK4 proteins, and changes the thinking about how either p16 loss or overexpression of cyclin D-dependent kinases contribute to cancer.
Journal ArticleDOI
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff,Thomas J. Ervin,Francis P. Arena,E. Gabriela Chiorean,Jeffrey R. Infante,Malcolm J. Moore,Thomas E. Seay,Sergei Tjulandin,Wen Wee Ma,Mansoor N. Saleh,Marion Harris,Michele Reni,Scot Dowden,Daniel A. Laheru,Nathan Bahary,Ramesh K. Ramanathan,Josep Tabernero,Manuel Hidalgo,David Goldstein,Eric Van Cutsem,Xinyu Wei,Jose Iglesias,Markus F. Renschler +22 more
TL;DR: In patients with metastatic pancreatic adenocarcinoma, nab-paclitaxel plus gemcitabine significantly improved overall survival, progression-free survival, and response rate, but rates of peripheral neuropathy and myelosuppression were increased.
Journal ArticleDOI
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.
Lyubomir T. Vassilev,Binh Thanh Vu,Bradford Graves,Daisy Carvajal,Frank John Podlaski,Zoran Filipovic,Norman Kong,Ursula Kammlott,Christine Lukacs,Christian Klein,Nader Fotouhi,Liu Emily Aijun +11 more
TL;DR: In this article, the authors identify potent and selective small-molecule antagonists of MDM2 and confirm their mode of action through the crystal structures of complexes, leading to cell cycle arrest, apoptosis, and growth inhibition of human tumor xenografts.
Journal ArticleDOI
Mdm2 promotes the rapid degradation of p53
TL;DR: It is proposed that the Mdm2-promoted degradation of p53 provides a new mechanism to ensure effective termination of the p53 signal.
Journal ArticleDOI
5-Fluorouracil: mechanisms of action and clinical strategies
TL;DR: This work has shown that novel genes identified in DNA microarray profiling have the potential to identify novel genes that are involved in mediating resistance to 5-FU, and these genes might prove to be therapeutically valuable as new targets for chemotherapy, or as predictive biomarkers of response to5-FU-based chemotherapy.